51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04927390 (ClinicalTrials.gov)	December 8, 2021	19/5/2021	Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)	A Randomised Prospective Open Label Pilot Trial Comparing Mycophenolate Mofetil (MMF) With no Immunosuppression in Adults With Limited Cutaneous Systemic Sclerosis	Systemic Sclerosis;Limited Cutaneous Systemic Sclerosis	Drug: Mycophenolate Mofetil 500mg	University College, London	Versus Arthritis	Recruiting	18 Years	N/A	All	120	Phase 2	United Kingdom
2	NCT03221257 (ClinicalTrials.gov)	November 28, 2017	12/7/2017	Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate	Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease	Scleroderma, Systemic;Interstitial Lung Disease	Drug: Pirfenidone (PFD);Drug: Placebo (Plac);Drug: Mycophenolate Mofetil (MMF)	Michael Roth	University of Michigan;Genentech, Inc.;University of California, Los Angeles	Completed	18 Years	N/A	All	51	Phase 2	United States